

#149 Asthma Management and the MANDALA Trial: Beyond Journal Club with NEJM Group
23 snips Apr 10, 2024
Explore the evolving story of asthma management and the key players in this field. Learn about the impact of the MANDALA Trial, which shows the benefits of a combination inhaler for asthma. Delve into the debate on early medication initiation and optimizing asthma care with updated guidelines. Discover the importance of smart therapy and proper inhaler use for enhanced asthma management.
AI Snips
Chapters
Transcript
Episode notes
Asthma Misconceptions
- Asthma is commonly misunderstood, with outdated treatment approaches persisting.
- Traditional teachings often overlooked the inflammatory component of asthma.
Importance of ICS
- Inhaled glucocorticoids (ICS) are crucial for managing asthma's underlying inflammation.
- Albuterol, while providing temporary relief, does not address this core issue.
Inhaler Mnemonic
- Remember ICS medications by their "ONE" endings (e.g., beclomethasone, fluticasone).
- Differentiate LABAs from SABAs: LABAs typically end in "ol" (excluding albuterol/levalbuterol).